Clinical Trials Browser

Leukemia, Myeloid, Acute × ADI PEG20 × 90 days × Clear all

NCT05001828 2026-01-21

Study of ADI-PEG 20, Venetoclax and Azacitidine in Acute Myeloid Leukemia

Phase 1 Active not recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute